Viridian Therapeutics, Inc. (VRDN)
19.03
-0.53
(-2.71%)
USD |
NASDAQ |
Oct 16, 16:00
18.76
-0.27
(-1.42%)
After-Hours: 20:00
Viridian Therapeutics Net Income (TTM) : -368.60M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -368.60M |
| March 31, 2026 | -342.21M |
| December 31, 2025 | -324.22M |
| September 30, 2025 | -286.89M |
| June 30, 2025 | -328.98M |
| March 31, 2025 | -293.24M |
| December 31, 2024 | -254.87M |
| September 30, 2024 | -257.08M |
| June 30, 2024 | -228.06M |
| March 31, 2024 | -218.12M |
| December 31, 2023 | -237.73M |
| September 30, 2023 | -216.66M |
| June 30, 2023 | -197.90M |
| March 31, 2023 | -172.33M |
| December 31, 2022 | -129.87M |
| September 30, 2022 | -113.04M |
| June 30, 2022 | -98.17M |
| March 31, 2022 | -86.65M |
| December 31, 2021 | -79.41M |
| September 30, 2021 | -141.21M |
| June 30, 2021 | -132.66M |
| March 31, 2021 | -121.13M |
| December 31, 2020 | -110.72M |
| September 30, 2020 | -30.09M |
| June 30, 2020 | -35.83M |
| Date | Value |
|---|---|
| March 31, 2020 | -38.29M |
| December 31, 2019 | -41.87M |
| September 30, 2019 | -42.07M |
| June 30, 2019 | -39.85M |
| March 31, 2019 | -39.67M |
| December 31, 2018 | -32.70M |
| September 30, 2018 | -28.77M |
| June 30, 2018 | -25.60M |
| March 31, 2018 | -24.19M |
| December 31, 2017 | -26.52M |
| September 30, 2017 | -26.12M |
| June 30, 2017 | -24.45M |
| March 31, 2017 | -19.64M |
| December 31, 2016 | -15.42M |
| September 30, 2016 | -12.41M |
| June 30, 2016 | -11.40M |
| March 31, 2016 | -11.45M |
| December 31, 2015 | -11.33M |
| September 30, 2015 | -10.61M |
| June 30, 2015 | -9.091M |
| March 31, 2015 | -9.818M |
| December 31, 2014 | -7.387M |
| September 30, 2014 | -5.854M |
| June 30, 2014 | -4.925M |
| December 31, 2013 | -3.760M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.405B |
| TG Therapeutics, Inc. | 441.49M |
| Travere Therapeutics, Inc. | -67.68M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |